Systemic vs. Topical Therapy for the Treatment of Vulvovaginal Candidiasis
It is estimated that 75% of all women will experience at least 1 episode of vulvovaginal candidiasis (VVC) during their lifetimes. Most patients with acute VVC can be treated with short-term regimens that optimize compliance. Since current topical and oral antifungals have shown comparably high effi...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Hindawi Limited,
1994-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|